6[2]Robinson.Osteoclasts and transforming growth factor-beta:estrogen-medi-ated isoform-specific regulation of production.Endorinology,1996,137(2):615.
7Karakoc B, Erenus M .Compliance considerations with hormone replacement therapy. Menopause, 1998 , 5(2): 102-106.
8Elliott ME, Meek PD, Kanous NL,et al.Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother, 2002 , 36(4): 571-577.
9Silverman SL, Greenwald M, Klein RA,et al.Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol, 1997 , 89(3): 321-325 .
10Sedlak CA ,Doheny MO, Jones SL. Osteoporosis prevention in young women. Orthop Nurs. 1998, 17(3):53-56.
